209 related articles for article (PubMed ID: 37336123)
1. Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease.
Han YH; He XM; Jin MH; Sun HN; Kwon T
Biochem Biophys Res Commun; 2023 Sep; 672():36-44. PubMed ID: 37336123
[TBL] [Abstract][Full Text] [Related]
2. Autophagy and Lipid Droplets in the Liver.
Martinez-Lopez N; Singh R
Annu Rev Nutr; 2015; 35():215-37. PubMed ID: 26076903
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Lipophagy and Chaperone-Mediated Autophagy in the Pathogenesis of Non-Alcoholic Fatty Liver Disease by Regulation of Lipid Droplets.
Mastoridou EM; Goussia AC; Kanavaros P; Charchanti AV
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958873
[TBL] [Abstract][Full Text] [Related]
4. Lipophagy and liver disease: New perspectives to better understanding and therapy.
Zhang Z; Yao Z; Chen Y; Qian L; Jiang S; Zhou J; Shao J; Chen A; Zhang F; Zheng S
Biomed Pharmacother; 2018 Jan; 97():339-348. PubMed ID: 29091883
[TBL] [Abstract][Full Text] [Related]
5. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
6. Lipophagy mediated carbohydrate-induced changes of lipid metabolism via oxidative stress, endoplasmic reticulum (ER) stress and ChREBP/PPARγ pathways.
Zhao T; Wu K; Hogstrand C; Xu YH; Chen GH; Wei CC; Luo Z
Cell Mol Life Sci; 2020 May; 77(10):1987-2003. PubMed ID: 31392349
[TBL] [Abstract][Full Text] [Related]
7. Targeting lipophagy as a potential therapeutic strategy for nonalcoholic fatty liver disease.
Li HY; Peng ZG
Biochem Pharmacol; 2022 Mar; 197():114933. PubMed ID: 35093393
[TBL] [Abstract][Full Text] [Related]
8. Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease.
Zhang Y; Chen Y
Chin Med J (Engl); 2022 Jul; 135(14):1673-1681. PubMed ID: 35950774
[TBL] [Abstract][Full Text] [Related]
9. The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders.
Zhang S; Peng X; Yang S; Li X; Huang M; Wei S; Liu J; He G; Zheng H; Yang L; Li H; Fan Q
Cell Death Dis; 2022 Feb; 13(2):132. PubMed ID: 35136038
[TBL] [Abstract][Full Text] [Related]
10. [Exercise regulates lipid metabolism via lipophagy and its molecular mechanisms].
Li MY; Li LJ; Ma CW; Gao BH
Sheng Li Xue Bao; 2022 Apr; 74(2):309-319. PubMed ID: 35503079
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of lipophagy in liver disorders.
Nazeer B; Khawar MB; Khalid MU; Hamid SE; Rafiq M; Abbasi MH; Sheikh N; Ali A; Fatima H; Ahmad S
Mol Cell Biochem; 2024 Jan; 479(1):1-11. PubMed ID: 36943663
[TBL] [Abstract][Full Text] [Related]
12. Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy.
Gao Y; Zhang W; Zeng LQ; Bai H; Li J; Zhou J; Zhou GY; Fang CW; Wang F; Qin XJ
Redox Biol; 2020 Sep; 36():101635. PubMed ID: 32863214
[TBL] [Abstract][Full Text] [Related]
13. Bergamot polyphenol fraction prevents nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat model of metabolic syndrome.
Parafati M; Lascala A; Morittu VM; Trimboli F; Rizzuto A; Brunelli E; Coscarelli F; Costa N; Britti D; Ehrlich J; Isidoro C; Mollace V; Janda E
J Nutr Biochem; 2015 Sep; 26(9):938-48. PubMed ID: 26025327
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease.
Du J; Ji X; Xu B; Du Q; Li Y; Zhou B; Liu X; Xu Z; Jiang Y; Kou B; Li Z; Cui C; Lin J
Metabolism; 2024 Mar; 152():155769. PubMed ID: 38158076
[TBL] [Abstract][Full Text] [Related]
15. PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes.
Negoita F; Blomdahl J; Wasserstrom S; Winberg ME; Osmark P; Larsson S; Stenkula KG; Ekstedt M; Kechagias S; Holm C; Jones HA
J Cell Biochem; 2019 Jan; 120(1):343-356. PubMed ID: 30171718
[TBL] [Abstract][Full Text] [Related]
16. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
[TBL] [Abstract][Full Text] [Related]
17. Exercise ameliorates lipid droplet metabolism disorder by the PLIN2-LIPA axis-mediated lipophagy in mouse model of non-alcoholic fatty liver disease.
Fang C; Liu S; Yang W; Zheng G; Zhou F; Gao X; Qin L; Yang G; Yang J; Zhu G; Wang X; Huang K; Yang X; Wei Y; Peng S; Li L
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167045. PubMed ID: 38306800
[TBL] [Abstract][Full Text] [Related]
18. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
[TBL] [Abstract][Full Text] [Related]
19. Exercise improves lipid droplet metabolism disorder through activation of AMPK-mediated lipophagy in NAFLD.
Li H; Dun Y; Zhang W; You B; Liu Y; Fu S; Qiu L; Cheng J; Ripley-Gonzalez JW; Liu S
Life Sci; 2021 May; 273():119314. PubMed ID: 33667513
[TBL] [Abstract][Full Text] [Related]
20. Naringin Protects against Non-Alcoholic Fatty Liver Disease by Promoting Autophagic Flux and Lipophagy.
Guan L; Guo L; Zhang H; Liu H; Zhou W; Zhai Y; Yan X; Men X; Peng L
Mol Nutr Food Res; 2024 Feb; 68(3):e2200812. PubMed ID: 38054638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
